Autologous Serum Skin Test and Serum IL-18 Levels in Chronic Idiopathic Urticaria and Respiratory Allergic Diseases
NCT ID: NCT01091402
Last Updated: 2010-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
OBSERVATIONAL
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Frequency of Parasite Infestation in Patients With Chronic Spontaneous Urticaria
NCT04314999
The Efficacy & Safety of the UAS Immunotherapy Protocol
NCT01699659
The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study
NCT06806826
Validation of an Allergic Rhinitis Control Test in Teenagers
NCT02818153
An Open Label, Randomized, Parallel, Comparative Pharmacokinetic Study in Healthy Subjects.
NCT06929052
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
chronic urticaria
autologous serum skin test, serum IL-18
asthma
autologous serum skin test, serum IL-18
seasonal allergic rhinitis
autologous serum skin test, serum IL-18
normal controls
autologous serum skin test, serum IL-18
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
autologous serum skin test, serum IL-18
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* chronic urticaria patients
* stable asthma patients
* allergic rhinitis patients with sensitized to pollens
* normal controls without atopic and skin disease.
Exclusion Criteria
* other dermatological problems that could affect the skin test
* use of antihistamine drugs
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eskisehir Osmangazi University
OTHER
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eskisehir Osmangazi University
Eskişehir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.